Bain Capital Private Equity

Bain Capital Private Equity, LP is a private equity and venture capital firm that specializes in a diverse range of investment strategies, including control buyouts, growth capital, and turnaround situations. The firm invests across several sectors, such as consumer, financial services, healthcare, industrial, and technology. In the consumer sector, it targets areas like retail and food services, while in financial services, it focuses on payment systems and business outsourcing. The healthcare investments include medical devices and life sciences, and the industrial sector encompasses automotive and manufacturing. In technology, Bain Capital invests in software, hardware, and digital media. The firm primarily seeks investments in North America, Europe, and select countries in Asia, with a typical investment range between $5 million and $1 billion. Founded in 1984 and headquartered in Boston, Bain Capital Private Equity emphasizes a collaborative approach, leveraging industry expertise to drive growth in its portfolio companies.

Richard Albright

MD of Investor Relations

Samonnoi Banerjee

Managing Director

Steven W. Barnes

MD

Joshua Bekenstein

Co-Chairman, Bain Capital

Cécile Belaman

Managing Director

Jonathan Belitsos

Principal

Andrej Busch

Operating Partner

Giovanni Camera

Principal

Drew Chen

Managing Director

Jay Corrigan

Managing Director and CFO

Ryan Cotton

Managing Director

Stephen Dando

Managing Director

David Danon

Principal and Member of the European Private Equity team

Robert Ehrhart

Managing Director

Robert Farkas

Executive VP and Member of the North American Private Equity team

Max De Groen

Principal

Blair Hendrix

Managing Director

David Humphrey

Managing Director

Andrew Kaplan

Principal

John Kilgallon

Managing Director

Phil Loughlin

Managing Director

Philip H. Loughlin

MD

Kim McCaslin

Managing Director

T. Devin O'Reilly

Managing Director

Steve Pagliuca

Co-Chairman, Bain Capital

Joseph Robbins

Managing Director

Jeff Scherer

Managing Director

Michael Siefke

Managing Director

Stephen F. Thomas

Managing Director

Nigel Walder

Managing Director

18 past transactions

Cardurion Pharmaceuticals

Venture Round in 2021
Cardurion Pharmaceuticals, LLC operates as a biotechnology company. The company was incorporated in 2017 and is based in Boston, Massachusetts.

PartsSource inc.

Acquisition in 2021
PartsSource provides the medical equipment service industry with proprietary software solutions related to the acquisition and life cycle management of medical repair parts. The company has been recognized by clinical engineers and healthcare executives alike for its unique ePartsFinder® application for its ability to increase department efficiencies while reducing costs through its award-winning SmartPrice™ technology.

ExtraHop Networks

Acquisition in 2021
ExtraHop Networks, Inc. specializes in real-time wire data analytics solutions aimed at enhancing application and infrastructure monitoring. Its flagship platform enables IT organizations to proactively identify and resolve issues, collaborate effectively, and support various IT initiatives such as migrations and compliance audits. The company’s offerings include ExtraHop Addy, which leverages machine learning for real-time situational insights, and Reveal(x) 360, a SaaS-based network detection and response solution that provides comprehensive visibility across multicloud and hybrid environments. Additionally, ExtraHop develops solutions for network traffic analysis, particularly tailored for enterprise security and cloud operations. The company serves a diverse clientele, including healthcare organizations, financial services, retail, technology providers, and government entities. Founded in 2007 and headquartered in Seattle, Washington, ExtraHop Networks aims to empower enterprises with the operational intelligence necessary for agile and proactive IT management.

Valeo Foods Ltd.

Acquisition in 2021
Valeo Foods Group is one of Europe’s fastest growing consumer foods producers, with a portfolio of category leading brands, many of them iconic household names. Valeo Foods produces and sells over six hundred million units a year from its state-of-the-art manufacturing facilities across Ireland, the UK and Continental Europe.

Dessert Holdings

Acquisition in 2021
Dessert is manufacturer of high-quality frozen desserts for retail and foodservice customer.

pulseData

Series A in 2021
pulseData, Inc. is a New York-based company founded in 2015 that specializes in developing machine learning software tailored for healthcare providers. The company's platform leverages adaptive and predictive data science tools to identify patients at risk of adverse medical outcomes, enabling healthcare organizations to deliver targeted care to those who need it most. By analyzing vast amounts of data, including individual patient information and population patterns, pulseData aids care management teams in providing timely and effective interventions. This approach not only enhances patient care but also aims to reduce preventable illnesses and optimize medical cost savings for healthcare enterprises.

Newlinks Technology

Private Equity Round in 2021
Newlinks Technology is a car refueling service provider, mainly providing one-button cardless refueling service. The application recommends a gas station for the user and offers membership subscription, discounts, and more. In addition, it also provides car maintenance, 4S services, tire services, auto insurance, car care, and other services. Newlinks Technology was founded on 2016.

Lonza

Acquisition in 2021
Lonza Group AG, a Life Sciences driven chemical company, supplies active ingredients, chemical intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries. The company also offers a catalogue of organic intermediates for a range of applications, such as pharmaceuticals, agrochemicals, vitamins, food and feedstuff, dyes and pigments, adhesives and fragrances. It also manufactures specialty biocides and oleochemicals; and develops and produces specific polymer intermediates, unsaturated polyester-resins, compounds and composites. The company operates in three divisions that include Exclusive Synthesis & Biopharmaceuticals; Organic Fine & Performance Chemicals; and Polymer Intermediates. Exclusive Synthesis & Biopharmaceuticals In the area of Exclusive Synthesis and Biopharmaceuticals, Lonza is the custom manufacturing for the global life sciences companies. In addition to Lonza's traditional chemical custom manufacturing, Lonza offers microbial custom fermentation and biotransformation services. Lonza Biologics is focused on the production of therapeutic monoclonal antibodies and recombinant proteins produced by mammalian cell cultures. Exclusive chemical synthesis: Exclusive chemical synthesis engages in the process development and manufacture of intermediates and active ingredients. It is used in Life sciences industry, pharmaceuticals and animal health products. Exclusive microbial fermentation and biotransformation: Exclusive microbial fermentation and biotransformation processes development and manufactures intermediates, active ingredients and biopharmaceuticals. Its products are used Life sciences industry, pharmaceuticals and cosmetics. The company also offers L-Carnitine (L-Carnipure), which is applicable in sports nutrition, food, pharmaceuticals and feedstuffs. Exclusive microbial biopharma fermentation: Exclusive microbial biopharma fermentation engages in the process development and manufacture of therapeutic recombinant proteins and antibody fragments. It is used in pharmaceutical and biotechnology industry. Exclusive mammalian cell fermentation: Exclusive mammalian cell fermentation engages in the process development and manufacture of therapeutic monoclonal antibodies and recombinant proteins, proprietary GS-expression system, which are used in the pharmaceutical and biotechnology industry. Organic Fine & Performance Chemicals In the area of organic fine and performance chemicals, the company develops, manufactures, and sells various organic chemical intermediates applied in pharmaceuticals, agrochemicals, vitamins, food and feed, dyes, pigments, adhesives, and fragrances, as well as polymers. The sector performance chemical is mainly engaged in the development and production of biocides and oleochemicals. These core activities are supplemented by the polymer intermediates business, including additives, unsaturated polyester resins, compounds, and composites. Organic Fine Chemicals: The company offers Niacin, niacinamide, Diketene derivatives, Hydrocyanic acid derivatives, Engineering polymer additives and Meta – Metaldehyde. Its products are used in food and feedstuffs, pharmaceuticals, agrochemicals, colorants Vitamins, optical brighteners, agrochemicals, electronics, aerospace industry, and coating Snail. Performance Chemicals: The company offers microbiologically active substances, such as Quaternary ammonium, compounds, Halogenated hydantoins; and Hydantoin derivatives. It also offers Oleochemical derivatives. The company's products are used by the disinfectants for household, industrial and institutional applications, including water treatment and wood preservation; biocides for water treatment, pools and spas, and household disinfection; preservatives for personal care and household products; and food ingredients, humectants and emollients for personal care, processing aids and lubricants for polymer and textile industry, and industrial defoamers.

US LBM

Acquisition in 2020
US LBM is a building materials company that provides lumber and building materials.

Advantage Solutions

Post in 2020
Advantage Solutions Inc. is a global promotions agency based in Irvine, California, specializing in sales and marketing solutions. Established in 1987, the company offers a range of services, including headquarter sales, retail merchandising, and diverse marketing strategies such as shopper, experiential, and digital marketing. It serves various industries, including grocery, drugstore, convenience, and foodservice. With a workforce exceeding 50,000 associates and a presence in the United States, Canada, and Europe, Advantage Solutions is dedicated to enhancing brand value for its clients through tailored solutions. The company was formerly known as Karman Holding Corp. before adopting its current name in 2016.

Nutanix

Post in 2020
Nutanix is a cloud software company that provides a comprehensive enterprise cloud platform, enabling organizations to build and manage hybrid multi-cloud infrastructures. Founded in 2009 and headquartered in San Jose, California, Nutanix offers a range of solutions, including Acropolis for virtualization and storage, Nutanix Prism for management and analytics, and Nutanix Calm for application lifecycle automation. The company's services also encompass software-defined storage solutions, cloud-native environment management, and disaster recovery services. Notably, Nutanix Beam, a multi-cloud optimization service, enhances cloud cost efficiency by delivering insights into consumption patterns and automating security compliance. Serving diverse industries such as healthcare, finance, and technology, Nutanix aims to simplify IT operations, allowing businesses to focus on innovation while efficiently managing their data and applications across various environments.

Kestra Medical Technologies

Private Equity Round in 2020
Kestra Medical Technologies, Inc. specializes in the development and manufacturing of wearable medical devices aimed at monitoring and managing acute medical conditions, particularly in the cardiac care sector. Founded in 2014 and headquartered in Kirkland, Washington, the company offers innovative solutions that enable the collection, communication, and storage of patient performance data, facilitating both real-time and retrospective analysis. Among its primary products is a wearable cardioverter defibrillator designed to prevent sudden cardiac death and support cardiac recovery in at-risk patients. These devices integrate advanced technologies to deliver vital information, thereby enhancing the ability of patients and their healthcare teams to monitor and manage health effectively.

Imperial Dade

Acquisition in 2019
Imperial Dade distributes foodservice disposables and janitorial supplies to restaurants, supermarkets, cruise lines, hotels and motels, schools, convention centers, stadiums, and other foodservice establishments. Dade primarily services the Southeast and Mid-Atlantic markets reaching from Florida to Maryland with additional locations in the Tri-State and Northeast regions. Dade Paper is a leading distributor of foodservice disposables and janitorial supplies serving customers across more than twenty states with an emphasis on supermarkets, foodservice providers, cruise lines and schools.

Maesa

Acquisition in 2019
Maesa SA, based in Levallois Perret, France, specializes in designing and manufacturing custom perfumes, cosmetics, and promotional products for a global market that includes Europe, Asia, and North America. Established in 1997, the company offers a comprehensive suite of services, including brand identity development, industrial and package design, and graphic design. Maesa creates turnkey beauty products and home fragrance offerings tailored for retailers and brands, alongside providing packaging components and promotional items specifically for the beauty industry. The company also acts as a beauty brand incubator, producing exclusive brands and private labels while offering outsourcing services that leverage its design, merchandising, and production capabilities.

Brillio

Private Equity Round in 2019
Brillio, LLC, a technology consulting company, provides digital transformation services. The company offers services in the areas of digital experiences, product engineering, digital front office, big data and analytics, digital infrastructure, and more. It serves banking and finance, energy and utilities, CPG, retail, technology, and media and entertainment industries worldwide. The company was incorporated in 2004 and is based in Santa Clara, California. As of January 15, 2020, Brillio, LLC operates as the subsidiary of Bain Capital Private Equity, LP.

Cerevel Therapeutics

Private Equity Round in 2018
Cerevel (www.cerevel.com) is a biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS). The company has a portfolio of pre-commercial neuroscience assets, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders including Parkinson’s, Alzheimer’s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.

Dealer Tire

Acquisition in 2018
Dealer Tire, LLC is a distributor of replacement tires and parts, primarily serving original equipment manufacturers (OEMs) and their dealerships in the United States and Canada. Founded in 1999 and headquartered in Cleveland, Ohio, the company specializes in designing, implementing, and managing tire programs that enhance customer satisfaction, safety, and retention. By providing comprehensive solutions, Dealer Tire enables automotive dealers and OEMs to effectively sell tires, accessories, services, and parts, fostering customer loyalty and driving business growth.

QuVa Pharma

Private Equity Round in 2018
QuVa Pharma will be the industry’s leading 503B platform and the partner of choice for compliance-oriented healthcare facilities looking to ensure quality, safe and consistent supply of medications. QuVa Pharma will achieve this through its commitment to innovation, by operating from superior facilities under stringent cGMP adherence, and by attracting individuals absolutely committed to quality and who bring deep sterile injectable manufacturing expertise.